237 related articles for article (PubMed ID: 32977498)
1. Syndecan-1 Promotes Hepatocyte-Like Differentiation of Hepatoma Cells Targeting Ets-1 and AP-1.
Hollósi P; Váncza L; Karászi K; Dobos K; Péterfia B; Tátrai E; Tátrai P; Szarvas T; Paku S; Szilák L; Kovalszky I
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32977498
[TBL] [Abstract][Full Text] [Related]
2. Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway.
Yu S; Lv H; Zhang H; Jiang Y; Hong Y; Xia R; Zhang Q; Ju W; Jiang L; Ou G; Zhang J; Wang S; Zhang J
Biochem Biophys Res Commun; 2017 Apr; 485(2):432-439. PubMed ID: 28209511
[TBL] [Abstract][Full Text] [Related]
3. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
4. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.
Derksen PW; Keehnen RM; Evers LM; van Oers MH; Spaargaren M; Pals ST
Blood; 2002 Feb; 99(4):1405-10. PubMed ID: 11830493
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-1 enhances proliferation, migration and metastasis of HT-1080 cells in cooperation with syndecan-2.
Péterfia B; Füle T; Baghy K; Szabadkai K; Fullár A; Dobos K; Zong F; Dobra K; Hollósi P; Jeney A; Paku S; Kovalszky I
PLoS One; 2012; 7(6):e39474. PubMed ID: 22745764
[TBL] [Abstract][Full Text] [Related]
6. [Proteoglycans in the liver].
Kovalszky I; Dudás J; Gallai M; Hollósi P; Tátrai P; Tátrai E; Schaff Z
Magy Onkol; 2004; 48(3):207-13. PubMed ID: 15520870
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate chains of syndecan-1 regulate ectodomain shedding.
Ramani VC; Pruett PS; Thompson CA; DeLucas LD; Sanderson RD
J Biol Chem; 2012 Mar; 287(13):9952-9961. PubMed ID: 22298773
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
9. Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance.
Deng Y; Foley EM; Gonzales JC; Gordts PL; Li Y; Esko JD
Hepatology; 2012 Jan; 55(1):277-86. PubMed ID: 21898481
[TBL] [Abstract][Full Text] [Related]
10. The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.
Ramani VC; Purushothaman A; Stewart MD; Thompson CA; Vlodavsky I; Au JL; Sanderson RD
FEBS J; 2013 May; 280(10):2294-306. PubMed ID: 23374281
[TBL] [Abstract][Full Text] [Related]
11. Suppressive effect of syndecan ectodomains and N-desulfated heparins on osteoclastogenesis via direct binding to macrophage-colony stimulating factor.
Kim JM; Lee K; Kim MY; Shin HI; Jeong D
Cell Death Dis; 2018 Nov; 9(11):1119. PubMed ID: 30389911
[TBL] [Abstract][Full Text] [Related]
12. Properdin Pattern Recognition on Proximal Tubular Cells Is Heparan Sulfate/Syndecan-1 but Not C3b Dependent and Can Be Blocked by Tick Protein Salp20.
Lammerts RGM; Talsma DT; Dam WA; Daha MR; Seelen MAJ; Berger SP; van den Born J
Front Immunol; 2020; 11():1643. PubMed ID: 32849563
[No Abstract] [Full Text] [Related]
13. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells.
Abiru S; Nakao K; Ichikawa T; Migita K; Shigeno M; Sakamoto M; Ishikawa H; Hamasaki K; Nakata K; Eguchi K
Hepatology; 2002 May; 35(5):1117-24. PubMed ID: 11981761
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of the apolipoprotein F (ApoF) gene by ETS and C/EBPα in hepatoma cells.
Shen XB; Huang L; Zhang SH; Wang DP; Wu YL; Chen WN; Xu SH; Lin X
Biochimie; 2015 May; 112():1-9. PubMed ID: 25726912
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7/ syndecan-1/TGF-β autocrine loop.
Zeng Y; Yao X; Chen L; Yan Z; Liu J; Zhang Y; Feng T; Wu J; Liu X
Oncotarget; 2016 Sep; 7(39):63324-63337. PubMed ID: 27556509
[TBL] [Abstract][Full Text] [Related]
16. The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice.
Trierweiler C; Hockenjos B; Zatloukal K; Thimme R; Blum HE; Wagner EF; Hasselblatt P
Cell Death Differ; 2016 Apr; 23(4):576-82. PubMed ID: 26470729
[TBL] [Abstract][Full Text] [Related]
17. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway.
Wang J; Luo Z; Yao T; Li W; Pu J
J Cell Physiol; 2019 May; 234(5):6908-6916. PubMed ID: 30317590
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGFβ1 action and upregulating MMP14.
Regős E; Abdelfattah HH; Reszegi A; Szilák L; Werling K; Szabó G; Kiss A; Schaff Z; Kovalszky I; Baghy K
Matrix Biol; 2018 Aug; 68-69():474-489. PubMed ID: 29454902
[TBL] [Abstract][Full Text] [Related]
19. Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications.
García-Vilas JA; Medina MÁ
World J Gastroenterol; 2018 Sep; 24(33):3695-3708. PubMed ID: 30197476
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific inhibitory action of decorin on different hepatoma cell lines.
Horváth Z; Reszegi A; Szilák L; Dankó T; Kovalszky I; Baghy K
Cell Signal; 2019 Oct; 62():109354. PubMed ID: 31271881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]